These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9654898)
21. Health effects of prisons. Risks of syringe exchange programmes in prisons prevail. Langkamp H BMJ; 2000 Dec; 321(7273):1406-7. PubMed ID: 11099292 [No Abstract] [Full Text] [Related]
22. Syringe exchange in the United States: doing the simple things better? Maher L; Iversen J Addiction; 2009 Sep; 104(9):1448-50. PubMed ID: 19558566 [No Abstract] [Full Text] [Related]
23. Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs. Kuyper LM; Kerr T; Li K; Hogg RS; Tyndall MW; Montaner JS; Wood E Subst Use Misuse; 2006; 41(6-7):883-99. PubMed ID: 16809177 [TBL] [Abstract][Full Text] [Related]
27. Critical condition facing needle exchange programs: the politics of science. Sherman SG Subst Use Misuse; 2006; 41(6-7):827-9. PubMed ID: 16809169 [No Abstract] [Full Text] [Related]
28. Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment. Nguyen TQ; Weir BW; Des Jarlais DC; Pinkerton SD; Holtgrave DR AIDS Behav; 2014 Nov; 18(11):2144-55. PubMed ID: 24824043 [TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness of SEPs. Makulowich GS AIDS Patient Care STDS; 1998 Feb; 12(2):151-2. PubMed ID: 11361923 [No Abstract] [Full Text] [Related]
30. Needle exchange programs help prevent AIDS. Minn Med; 1993 Nov; 76(11):42. PubMed ID: 8295617 [No Abstract] [Full Text] [Related]
31. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Wodak A; Cooney A Subst Use Misuse; 2006; 41(6-7):777-813. PubMed ID: 16809167 [TBL] [Abstract][Full Text] [Related]
32. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island. Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657 [No Abstract] [Full Text] [Related]
34. On our failure to face the link between drug use and AIDS. Blansfield HN AIDS Public Policy J; 1996; 11(4):159-63. PubMed ID: 10915249 [TBL] [Abstract][Full Text] [Related]
35. Needle exchange: friend or foe. Nedjat-Shokouhi B Focus; 2002 Feb; 17(3):1-4. PubMed ID: 11968159 [No Abstract] [Full Text] [Related]
36. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users. Amundsen EJ Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880 [No Abstract] [Full Text] [Related]
37. Hepatitis C Prevention and Needle Exchange Programs in Rhode Island: ENCORE. Joseph R; Kofman A; Larney S; Fitzgerald P R I Med J (2013); 2014 Jul; 97(7):31-4. PubMed ID: 24983019 [TBL] [Abstract][Full Text] [Related]
38. HIV/AIDS: Latin America & Caribbean. Puerto Rico: rich port, poor port. Cohen J Science; 2006 Jul; 313(5786):475-6. PubMed ID: 16873644 [No Abstract] [Full Text] [Related]
39. The prevalence of HIV and AIDS among high-risk populations in Rhode Island, 2002. Fulton JP; Chiaverini L; Loberti P; Minuto L Med Health R I; 2002 Oct; 85(10):324-5. PubMed ID: 12412526 [No Abstract] [Full Text] [Related]